Alzheimer's Flashcards

(36 cards)

1
Q

is Alzheimer’s progressive or reversible

A

progressive and non reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

onset of Alzheimer’s

A

insidious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what age is classified as early onset Alzheimer’s

A

<65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how may early onset Alzheimer’s presentation vary

A

may be atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

are genetic factors or environemental factors more important in the development of early onset/Alzheimer’s

A

early onset, thinking genetic factors - maybe a mutation

population risk for AD is more due to multifactorial - genes, environement etc

look at ice Berg triangle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

are females or males more likely to get Alzheimer’s

A

females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

genetics of AD - which 3 mutations are associated

A
  • multifactorial, but increased risk with 1st degree relative (25%)
  • APP gene mutation - produces amyloid precuros protein, excess leads to formation of beta amyloid palques and tau tangles
  • PSEN genes
  • Inheriting Apoe4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

do lifestyle factors have an influence on the development of Alzheimer’s

A

yes, smoking midlife obesity, diet high in sat fats are risk factors

also, diabetes, smoking in mid-life, hypertension are found to be the greatest modifiable risk factors for dementia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cerebrovascular disease and Alzheimer’s

A

is a strong risk factor for vascular dementia, which often overlaps with Alzheimer’s

diabetes increases the risk of both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Down’s and Alzheimer’s

A

Down’s is assoicated with early onset Alzheimer’s

the presence of 3 copies of the APP gene on chromosome 21 accounts for this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which allele is a risk factor for Alzheimer’s

A

ApoE e4 allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which 3 things point towards a familial cause o disease

A

early onset

atypical form

relatives affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

senile plaques

A

EC deposits of amyloid beta in grey matter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how does amyloid beta form

A

mutations in the amyloid precursor protein leads to formation of abnormal amyloid beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what do senile plaques do

A

Senile plaques cause an inflammatory process through microglial activation, cytokine formation and activation of complement cascade. Inflammation leads to formation of neuritic plaques à cell death.

Leads to cortical atrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are neurofibrillary tangles made of

A

abnormal aggregates of tau protein

17
Q

is the number of neurofibrillary tangles important in disease severity?

A

number of tangles roughly proportional to severity of disease and cognitive decline

18
Q

what happens to cholinergic neurotransmission

A

the collection of neurons that produce ACh (called the nucleus basalis of Meynert) is affected early on in the disease process - decreased levels of cholingeric neurotransmission

19
Q

what happens to glutamine transmission

A

there are changes to the NMDA receptors - results in overativation of glutamate - excito!!!

20
Q

what are important points to elicit from history

A
  • timeline of progression
  • how ADL are affected eg financial affairs and medications
21
Q

what are the 3 common presenting symptoms

A

loss of recent memory

difficulty with exectuve function

nominal dysphasia

22
Q

what other features are common

A
  • Disorientation (e.g. things getting lost at first – this could also be due to visuo-spatial dysfunction)
  • Apathy
  • Deficits in visuo-spatial function (e.g. impaired performance in clock-drawing) and driving become evident as the disease progresses
  • Features such as prosopagnosia (not recognizing familiar faces) and auto prosopagnosia tend to develop later
23
Q

do changes in personality occur?

A

later in disease, unlike in other dementias

24
Q

physical examination

A

unremarkable in early stages.

In advanced disease patients may appear sloppily dressed, confused, apathetic, disorientated.

25
what is a good cognitive test to use initially
mini mental state examination
26
what tests would be done to rule out other causes on diagnosis
* FBC: to rule out anaemia * Metabolic panel * TSH – rule out hyper/hypothyroid associated dementia * Serum vitamin B12 * CT – exclude SOL etc.
27
what is seen on an MRI
generalised atrophy, temporal and lateral parietal predominance compensatory dilation of ventricles
28
what would examination of CSF show
increased tau level and decreased amyloid beta
29
what is the first step of management
to provide education, support and resources to patient and family
30
which risk factors must be addressed during management
vascular risk factors
31
pharmacological management
* Cholinesterase inhibitors (boost ACh): * Donepezil, Rivastigmine, Galantamine * Anti-glutaminergic treatment (NMDA blockers) * Memantine
32
how do cholinesterase inhibitors work
Increase brain ACh levels by inhibiting breakdown by CNS acetylcholinesterase
33
what benefit will cholinesterase inhibitors provide
they will not affect the underlying disease process, but will imrpove function and help pt maintain independece
34
what other dementia forms are cholinesterase inhibtors used in
DLB, parkinson's dementia
35
how does memantine work
it is an antagonist of the NMDA receptors - inhibits excessive glutamine activity
36
who would be prescribed memantine
* Moderate AD who are intolerant of/contraindication to cholinesterase inhibitors * Add on drug to cholinesterase inhibitors for moderate/severe AD * Monotherapy in severe AD